|
| Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo |
|
https://doi.org/10.18632/oncotarget.27380
Stephanie L. Merrigan, Bomina Park, Zaheer Ali, Lasse D. Jensen, Timothy W. Corson, Breandán N. Kennedy
|
| 493-509 |
|
| Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease |
|
https://doi.org/10.18632/oncotarget.27433
Manish Charan, Piyush Dravid, Maren Cam, Bhuvana Setty, Ryan D. Roberts, Peter J. Houghton, Hakan Cam
|
| 510-522 |
|
| Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response |
|
https://doi.org/10.18632/oncotarget.27458
James Jabalee, Rebecca Towle, James Lawson, Christopher Dickman, Cathie Garnis
|
| 523-534 |
|
| Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib |
|
https://doi.org/10.18632/oncotarget.27462
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster, Susanne Müller
|
| 535-549 |
|
| Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study |
|
https://doi.org/10.18632/oncotarget.27472
Beatrice Aramini, Federico Banchelli, Stefania Bettelli, Samantha Manfredini, Roberto D’Amico, Valentina Masciale, Massimo Pinelli, Margherita Moretti, Alessandro Stefani, Federica Bertolini, Massimo Dominici, Uliano Morandi, Antonino Maiorana
|
| 550-559 |
|
| Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas |
|
https://doi.org/10.18632/oncotarget.27342
Salvatore Lopez, Emanuele Perrone, Stefania Bellone, Elena Bonazzoli, Burak Zeybek, Chanhee Han, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Anna Bianchi, Luca Zammataro, Aranzazu Manzano, Paola Manara, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Francesco Raspagliesi, Roberto Angioli, Natalia Buza, Pei Hui, Heather M. Bond, Alessandro D. Santin
|
| 560-570 |
|
| Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts |
|
https://doi.org/10.18632/oncotarget.27440
Leonid Visochek, Dikla Atias, Itay Spektor, Asher Castiel, Talia Golan, Malka Cohen-Armon
|
| 571-572 |
|
| Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines |
|
https://doi.org/10.18632/oncotarget.27475
Elpetra Timmermans-Sprang, Rob W.J. Collin, Arjen Henkes, Meike Philipsen, Jan A. Mol
|
| 573-573 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
